Search by Drug Name or NDC
NDC 70515-0701-01 Omnaris 50 ug/1 Details
Omnaris 50 ug/1
Omnaris is a NASAL SPRAY in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Covis Pharma US, Inc. The primary component is CICLESONIDE.
MedlinePlus Drug Summary
Ciclesonide nasal spray is used to treat the symptoms of seasonal (occurs only at certain times of the year), and perennial (occurs all year round) allergic rhinitis. These symptoms include sneezing and stuffy, runny or itchy nose. Ciclesonide is in a class of medications called corticosteroids. It works by preventing and decreasing inflammation (swelling that can cause other symptoms) in the nose.
Related Packages: 70515-0701-01Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Ciclesonide Nasal Spray
Product Information
| NDC | 70515-0701 |
|---|---|
| Product ID | 70515-701_fa248cfa-08c9-43a3-8289-a28e5447cb1d |
| Associated GPIs | 42200018001820 |
| GCN Sequence Number | 061667 |
| GCN Sequence Number Description | ciclesonide SPRAY/PUMP 50 MCG NASAL |
| HIC3 | Q7P |
| HIC3 Description | NASAL ANTI-INFLAMMATORY STEROIDS |
| GCN | 97453 |
| HICL Sequence Number | 032691 |
| HICL Sequence Number Description | CICLESONIDE |
| Brand/Generic | Brand |
| Proprietary Name | Omnaris |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ciclesonide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SPRAY |
| Route | NASAL |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | ug/1 |
| Substance Name | CICLESONIDE |
| Labeler Name | Covis Pharma US, Inc |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA022004 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70515-0701-01 (70515070101)
| NDC Package Code | 70515-701-01 |
|---|---|
| Billing NDC | 70515070101 |
| Package | 1 POUCH in 1 CARTON (70515-701-01) / 1 BOTTLE, GLASS in 1 POUCH / 120 SPRAY in 1 BOTTLE, GLASS |
| Marketing Start Date | 2018-04-23 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 22.6422 |
| Pricing Unit | GM |
| Effective Date | 2023-05-17 |
| NDC Description | OMNARIS 50 MCG NASAL SPRAY |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis